{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:43:37Z","timestamp":1793720617664,"version":"4.6.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semarthrit.2026.152967","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:15:32Z","timestamp":1772784932000},"page":"152967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immune dysregulation and infection susceptibility in Anti-MDA5 dermatomyositis"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-5135","authenticated-orcid":false,"given":"Katherine E","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-3384","authenticated-orcid":false,"given":"Thomas","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-6953","authenticated-orcid":false,"given":"Syed B","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-025-01188-7","article-title":"Anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis: recent progress in pathophysiology and treatment","volume":"27","author":"Yoshida","year":"2025","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0002","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152967_bib0003","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti\u2013melanoma differentiation\u2013associated gene 5 antibody\u2013positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152967_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069825","article-title":"Characterization of rotavirus RNAs that activate innate immune signaling through the RIG-I-like receptors","volume":"8","author":"Uzri","year":"2013","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152967_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004081","article-title":"In vivo ligands of MDA5 and RIG-I in measles virus-infected cells","volume":"10","author":"Runge","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102424","article-title":"Regulation of type I and type III interferon induction in response to pathogen sensing","volume":"87","author":"Gewaid","year":"2024","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152967_bib0009","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3899\/jrheum.170165","article-title":"HLA-DRB1 alleles as genetic risk factors for the development of anti-MDA5 antibodies in patients with dermatomyositis","volume":"44","author":"Chen","year":"2017","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152967_bib0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/tan.13171","article-title":"Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population","volume":"90","author":"Lin","year":"2017","journal-title":"Hla"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152967_bib0011","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1002\/art.34657","article-title":"Brief report: Association of HLA\u2013DRB1* 0101\/* 0405 with susceptibility to anti\u2013melanoma differentiation\u2013associated gene 5 antibody\u2013positive dermatomyositis in the Japanese population","volume":"64","author":"Gono","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152967_bib0012","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/annrheumdis-2017-212149","article-title":"Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis","volume":"77","author":"Kochi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152967_bib0013","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/rheumatology\/kead006","article-title":"WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease","volume":"62","author":"Guo","year":"2023","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152967_bib0014","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/rheumatology\/keae183","article-title":"The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations","volume":"63","author":"Lyu","year":"2024","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/keac229","article-title":"Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease","volume":"62","author":"Xu","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.820163","article-title":"Rituximab in the treatment of interstitial lung diseases related to anti-melanoma differentiation-associated gene 5 dermatomyositis: a systematic review","volume":"12","author":"He","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0017","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaad.2010.08.004","article-title":"Enhanced skin expression of melanoma differentiation-associated gene 5 (MDA5) in dermatomyositis and related autoimmune diseases","volume":"64","author":"Zahn","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0018","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymyositis and dermatomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Care Res: Off J Am Coll Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0019","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/acr.22501","article-title":"A population-based study of infection-related hospital mortality in patients with dermatomyositis\/polymyositis","volume":"67","author":"Murray","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/1756-185X.13255","article-title":"Opportunistic infections in patients with idiopathic inflammatory myopathies","volume":"21","author":"Redondo-Benito","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.55563\/clinexprheumatol\/yps7ai","article-title":"Infection is not rare in patients with idiopathic inflammatory myopathies","volume":"40","author":"Ge","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152967_bib0022","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/biomedicines10123176","article-title":"Infection risk in patients with dermatomyositis associated with anti-MDA5 antibodies: a historical cohort study","volume":"10","author":"Billet","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0023","article-title":"Analysis of clinical features and risk factors for patients with idiopathic inflammatory myopathy complicated by Pneumocystis jirovecii pneumonia","author":"Li JH","year":"2025","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0024","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/rheumatology\/keaa436","article-title":"Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America","volume":"60","author":"Sabbagh","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13075-021-02606-8","article-title":"High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center","volume":"23","author":"Huang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0026","article-title":"Association of cytomegalovirus infection with anti-MDA5 antibody-positive dermatomyositis: a prospective cohort study","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0027","first-page":"1","article-title":"The characteristics and risk factors of Cytomegalovirus infection in dermatomyositis","author":"Zhang","year":"2024","journal-title":"Indian J Microbiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0028","first-page":"291","article-title":"Intensive induction therapy combining tofacitinib, rituximab and plasma exchange in severe anti-melanoma differentiation-associatedprotein-5 antibody-positive dermatomyositis","volume":"41","author":"Shirai","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152967_bib0029","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/mr\/road042","article-title":"Predicting the death of patients with anti-melanoma differentiation\u2013associated protein-5-positive dermatomyositis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"34","author":"Yang","year":"2024","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1346-8138.15274","article-title":"Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis","volume":"47","author":"Matsuda","year":"2020","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152967_bib0031","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/1346-8138.15409","article-title":"Demographic and clinical characteristics of cytomegalovirus reactivation in dermatomyositis","volume":"47","author":"Sekiguchi","year":"2020","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0032","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/v13020260","article-title":"Human cytomegalovirus and autoimmune diseases: where are we?","volume":"13","author":"Gugliesi","year":"2021","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152967_bib0033","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/CVI.00487-14","article-title":"Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy","volume":"21","author":"Prince","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152967_bib0034","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3892\/mmr.2017.6693","article-title":"Potential role of autophagy in T\u2011cell survival in polymyositis and dermatomyositis","volume":"16","author":"Shu","year":"2017","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12890-023-02706-y","article-title":"Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease","volume":"23","author":"Ren","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0036","first-page":"237","article-title":"Expansion of exhausted CD8+ T cells associates with increased pulmonary fungal infection risk in anti-melanoma differentiation associated gene 5 dermatomyositis","volume":"42","author":"Xu","year":"2024","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0037","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/jir.2013.0088","article-title":"Immunoregulatory effects of interferon-\u03b2 in suppression of Th17 cells","volume":"34","author":"Pennell","year":"2014","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0038","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1172\/JCI33342","article-title":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice","volume":"118","author":"Guo","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0039","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2008.05.008","article-title":"Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin","volume":"29","author":"Shinohara","year":"2008","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152967_bib0040","article-title":"Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation","volume":"6","author":"Zhang","year":"2011","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12865-023-00569-w","article-title":"Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies","volume":"24","author":"Lan","year":"2023","journal-title":"BMC Immunol"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0042","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.2147\/JIR.S509777","article-title":"Shared and distinctive inflammation-related protein profiling in idiopathic inflammatory myopathy with\/without anti-MDA5 autoantibodies","author":"Zhang","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.756018","article-title":"High-dimensional analysis reveals distinct endotypes in patients with idiopathic inflammatory myopathies","volume":"13","author":"Wilfong","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152967_bib0044","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/bjd.17079","article-title":"Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis","volume":"179","author":"Chen","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000286","article-title":"Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE","volume":"5","author":"Casey","year":"2018","journal-title":"Lupus Sci Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152967_bib0046","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"Jci Insight"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10067-017-3799-y","article-title":"Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis","volume":"37","author":"Peng","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0048","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-024-01933-x","article-title":"Neutrophil extracellular traps in homeostasis and disease","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117321","article-title":"Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis","volume":"543","author":"Lin","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1697803","article-title":"Exhaustion of NK cells and interferon activation in anti-MDA5+ dermatomyositis are associated and determine the development of ILD","volume":"16","author":"Shao","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-10895-1","article-title":"Dysregulated type I\/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis","volume":"15","author":"Yoshida","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0052","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/eji.201646762","article-title":"Jurani\u0107 Lisni\u0107 V. CMV and natural killer cells: shaping the response to vaccination","volume":"48","author":"Goodier","year":"2018","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152967_bib0053","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152967_bib0054","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.3821","article-title":"IFN-\u03bb suppresses intestinal inflammation by non-translational regulation of neutrophil function","volume":"18","author":"Broggi","year":"2017","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152967_bib0055","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jid.2019.10.020","article-title":"MDA5+ dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with upregulation of IFN-\u03ba transcript","volume":"140","author":"Cassius","year":"2020","journal-title":"J Investig Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0056","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/rheumatology\/key386","article-title":"The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients","volume":"58","author":"Ono","year":"2019","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0057","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bjd.16917","article-title":"Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis","volume":"180","author":"Zhang","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0058","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1038\/s41467-022-34145-4","article-title":"Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications","volume":"13","author":"Ye","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152967_bib0059","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152967_bib0060","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10067-020-05530-5","article-title":"Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy","volume":"40","author":"Ge","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002770","article-title":"Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study","volume":"9","author":"Abe","year":"2023","journal-title":"Rmd Open"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152967_bib0062","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/rheumatology\/keaa582","article-title":"The long-term prognosis of pneumomediastinum associated with dermatomyositis: a two-centre retrospective cohort study","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0063","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12931-025-03347-x","article-title":"Spontaneous pneumomediastinum and\/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system","volume":"26","author":"Jin","year":"2025","journal-title":"Respir Res"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0064","series-title":"Seminars in arthritis and rheumatism","article-title":"Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: prevalence, risk factors, and prognosis","author":"Jin","year":"2024"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152967_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-194412000-00001","article-title":"Malignant interstitial emphysema of the lungs and mediastinum as an important occult complication in many respiratory diseases and other conditions: an interpretation of the clinical literature in the light of laboratory experiment","volume":"23","author":"Macklin","year":"1944","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152967_bib0066","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0067","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002795","article-title":"Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis","volume":"9","author":"Ida","year":"2023","journal-title":"RMD Open"},{"issue":"02","key":"10.1016\/j.semarthrit.2026.152967_bib0068","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/rai2.12112","article-title":"Combination therapy with methylprednisolone, rituximab, and tofacitinib in antimelanoma differentiation-associated 5 gene dermatomyositis with rapidly progressive interstitial lung disease","volume":"4","author":"Manghani","year":"2024","journal-title":"Rheumatol Autoimmun"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152967_bib0069","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"Tsuji","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152967_bib0070","first-page":"1097","article-title":"Prophylaxis with Valganciclovir in anti\u2013Melanoma differentiation associated 5 gene antibody dermatomyositis: a cohort study in China","volume":"10","author":"Shanshan","year":"2025","journal-title":"JCR: J Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152967_bib0071","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2021-222006","article-title":"EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update","volume":"81","author":"Landew\u00e9","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152967_bib0072","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:58:00Z","timestamp":1789667880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":72,"alternative-id":["S0049017226000569"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152967","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation and infection susceptibility in Anti-MDA5 dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152967"}}